Latest Videos

Stephen Krieger, MD, Talks Ocrelizumab in RRMS and PPMS Treatment
Stephen Krieger, MD, an associate professor at Mount Sinai Hospital, discusses the impact that recently-approved drug ocrelizumab has on the state of multiple sclerosis care, as well as his patient-centered app that depicts the MS condition in a more accurate manner, at the 2017 Consortium of Multiple Sclerosis Centers in New Orleans.
More Videos >>

Focus

The Significance of Allergic Reactions to Vaccines
John Kelso, MD, Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, outlined the main points from the talks he gave at the AAAAI 2017 meeting in Atlanta, Georgia. Kelso explained that the most important message, he felt, had to do with the relationship between the influenza vaccine and egg allergies.

Feature

Guy G. T’Sjoen: Hormone Therapy for Transgender Individuals Saves Lives
Guy G. T’Sjoen, MD, PhD, of Ghent University in Belgium laid down a heavy-handed endorsement of hormone therapy for transitioning individuals at the Endocrine Society's Annual Meeting and Exposition, citing safety and evidence that it may bring down the community's startling suicide rates.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$